Es posible que la prescripcin de GLP-1 no est disponible en todos los estados
The study, published in the Endocrine Journal, saw a 266% increase in deep vein thrombosis (DVT) in people taking semaglutide drugs
Helps with Side Effects GLP-1 agonists are known to cause side effects like nausea, vomiting, and diarrhea, particularly in the early stages of treatment
Bottom line: MeAgain is a tracking and education app, not a clinical service
Patients should be aware of warning signs that indicate potentially serious complications or the need for treatment adjustment
These include liraglutide (Saxenda) and semaglutide (Wegovy), representing an expansion beyond their original diabetes indication and highlighting the broader metabolic impact of GLP-1 pathway activation